Navigation Links
Hormonal contraceptives associated with higher risk of female sexual dysfunction
Date:5/3/2010

Women taking non-oral and oral hormonal contraceptives were at highest risk of Female Sexual Dysfunction (FSD), according to a study of female German medical students published today in The Journal of Sexual Medicine. Interestingly, women taking non-hormonal contraceptives were at lowest risk for FSD, more than women not using any contraceptive.

"Sexual problems can have a negative impact on both quality of life and emotional well-being, regardless of age," said researcher Dr. Lisa-Maria Wallwiener of the University of Heidelberg, Germany. "FSD is a very common disorder, with an estimated prevalence of about two in five women having at least one sexual dysfunction, and the most common complaint appearing to be low desire."

"The causes of FSD are multifunctional and in recent years the possible role of hormonal contraception has been discussed," said fellow researchers Drs. Christian and Markus Wallwiener, University of Tuebingen, Germany. "Women tend to be aware that sexual dysfunction is often influenced by various factors such as stress and relationships, but our study has shown it might also be influenced by exogenous hormone application."

1,086 women were included in the study (roughly 2.5% of the overall female medical student population in Germany), who completed questionnaires designed to identify problems with sexual function, as well as other lifestyle factors including desire for children, pregnancy and whether they were smokers. 87.4% had used contraceptives in the last 6 months, and 97.3% had been sexually active within the last four weeks.

To analyse the effect of contraception on sexual function, women using multiple forms of contraception or who had not been sexually active within the last four weeks were excluded, leaving 1046 participants. Of this figure, 32.4% were considered at risk for FSD: 5.8% at high risk for hypoactive sexual desire disorder, 1% for arousal disorder, 1.2% for decreased lubri
'/>"/>

Contact: Jennifer Beal
medicalnews@wiley.com
44-012-437-70633
Wiley-Blackwell
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Breast cancer cells recycle to escape death by hormonal therapy
2. Major NSF grant boosts UNH research on hormonal genomics
3. The pill for him: Scientists find a hormonal on-and-off switch for male fertility
4. Soy germ-based supplement SE5-OH containing natural S-Equol examined for safety, hormonal influence
5. Texas A&M testing oral contraceptives for animals
6. Continuous oral contraceptives better at easing pain, bleeding
7. Oral contraceptives impair muscle gains in young women
8. Oral contraceptives impair muscle gains in young women
9. Study explains potential failure of oral contraceptives with obese women
10. Socioeconomic position associated with effectiveness of HIV drugs
11. Weight gain between first and second pregnancies associated with increased odds of male second child
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 2015  Automation and pre-processing are reducing the ... This is the first step toward a future ... unintrusive. An assortment of portal scanners, biometric collection ... will transform the passenger screening process. ... Airport Passenger Screening Market ( http://www.frost.com/nf2b ), ...
(Date:8/28/2015)... , August 28, 2015 According ... Training Market by Assessment Type (Pen & Paper Based, ... Training, Corporate Learning, Academic Research), Vertical and Region - ... and Training Market to grow from USD 2.4 Billion ... a Compound Annual Growth Rate (CAGR) of 25.6% from ...
(Date:8/24/2015)... 2015 The consulting company Frost & ... manufacturer DERMALOG and its customized solutions and products for ... of the Year Award". DERMALOG is particularly successful with a ... -Cross reference: Picture is available at AP Images ... On Thursday evening, in South Africa,s ...
Breaking Biology News(10 mins):The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 2The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 3The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 4Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 2Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 3Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 4Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3
... Chicago Stritch School of Medicine have received a five-year, ... to study vitamin D deficiency in people of African ... vitamin D levels and risks for certain chronic diseases, ... previous studies is "inconclusive and needs to be studied ...
... and the United States recently published their joint findings that ... have a hidden signature. Findings published this month in ... , demonstrate that up to seven months before an animal ... prion protein in the brain was being eradicated. This member ...
... be used to reduce levels of carbon dioxide in the ... suck in carbon dioxide from the air are being developed ... Edinburgh, with funding from the RCUK Energy Programme, led by ... one 1m2 unit containing the tiny tubes could adsorb (suck ...
Cached Biology News:Loyola receives NIH grant to study vitamin D deficiency in African populations 2Medical researchers in Canada and the US discover hidden side of prion diseases 2Collecting carbon in a concrete jungle 2
(Date:9/2/2015)... , Sept. 2, 2015 Veracyte, Inc. ... H. Anderson , president and chief executive officer, will ... Wednesday, September 16, 2015 at 10:30 a.m. ET in ... The live audio webcast and subsequent replay may ... webcast will be available shortly after conclusion of the ...
(Date:9/2/2015)... September 2, 2015 Biovista ... Wettbewerbs BeHEARD von 2015 bekanntgeben zu können. Hierbei ... Genomics Institute. Biovista unterstützt mit seiner ... die Behandlung anderer Krankheiten als denen, für die ... und sein Team bei der Wylder Nation ...
(Date:9/2/2015)... ... September 02, 2015 , ... Temarry ... their entire waste to energy process and continue to contribute to the sustainability ... , Temarry’s Waste to Energy process has been operating at their Mexico facility, ...
(Date:9/1/2015)... 2015 Swecure, ein ... und Entwicklung neuartiger Therapien für Störungen des ... Reizdarm konzentriert, erhält vom US Patent and ... Medikament patentiert wird. Das Medikament basiert auf ... verhindert und Entzündungen vorbeugt.   Das ...
Breaking Biology Technology:Veracyte to Present at Morgan Stanley Global Healthcare Conference 2Biovista sponsert die Forschung von Wylder Nation Foundation zum Thema Mangel an saurer Sphingomyelinase 2Temarry Recycling’s New $100,000 Waste to Energy Renovation 2Das Patent von Swecure zur Verhinderung von Allergien bei Kindern wird in den USA zugelassen 2
... Bio Base Europe is making,progress in the development of sustainable biofuels. The recent first crop of,genetically modified poplars of the Flemish Institute for Biotechnology (VIB),will be modified ... ... ... ...
... , March 14 /PRNewswire/ -- Results from a landmark study involving more than 9,000 people showed that the high blood pressure ... ... , , ... ...
... MDVN ) today announced that it will host a teleconference and webcast with management to discuss fourth quarter ... 4:30 p.m. Eastern Time . A press release for the fourth quarter and year ended on ... ... ...
Cached Biology Technology:Bio Base Europe: Flanders and the Netherlands Cooperate on Biofuels From Genetically Modified Poplars 2Bio Base Europe: Flanders and the Netherlands Cooperate on Biofuels From Genetically Modified Poplars 3NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 2NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 3NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 4NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 5NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 6NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 7NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 8NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 9NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 10NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 11NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 12NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 13Medivation Announces Fourth Quarter and Year-End 2009 Financial Results Teleconference and Webcast On March 15, 2010 2Medivation Announces Fourth Quarter and Year-End 2009 Financial Results Teleconference and Webcast On March 15, 2010 3